BRIGHT MINDS BIOSCIENCES INC. - Common Stock (DRUG)

CUSIP: 10919W405

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock
Shares outstanding
7,758,356
Total 13F shares
197,030
Share change
-15,733
Total reported value
$207,191
Price per share
$1.05
Number of holders
5
Value change
-$19,280
Number of buys
1
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 10919W405?
CUSIP 10919W405 identifies DRUG - BRIGHT MINDS BIOSCIENCES INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BRIGHT MINDS BIOSCIENCES INC. - Common Stock (DRUG) as of Q2 2024

As of 30 Jun 2024, BRIGHT MINDS BIOSCIENCES INC. - Common Stock (DRUG) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 197,030 shares. The largest 5 holders included AdvisorShares Investments LLC, JANE STREET GROUP, LLC, NATIONAL BANK OF CANADA /FI/, Aspire Private Capital, LLC, and BlackRock Inc.. This page lists 5 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.